Atlas Trials

Adebrelimab Combined With Oral Etoposide for Elderly Patients and Patients With Poor Performance Status in Small Cell Lung Cancer: An Exploratory Clinical Study

Clinical trial NCT07398560 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07398560
Sponsor
The Third Affiliated Hospital of Harbin Medical University
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Small Cell Lung Cancer
Start date
2026-02-01
Primary completion
2028-02-01
Enrollment
47

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.